| Date | Time | Source | Headline | Symbol | Company |
| 03/19/2010 | 8:00AM | Marketwired | Marshall Edwards, Inc. Receives Nasdaq Staff Determination | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 02/26/2010 | 6:06AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 02/10/2010 | 6:19AM | Edgar (US Regulatory) | Amended Report of Foreign Issuer (6-K/A) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 02/09/2010 | 3:30PM | Marketwired | Marshall Edwards, Inc.'s Action Intended to Regain Compliance With Nasdaq Share Price Rule, Benefit Shareholders | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 02/08/2010 | 8:00AM | Marketwired | Marshall Edwards, Inc. Announces Resignation of Christopher Naughton From Board of Directors | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 01/21/2010 | 6:33PM | Marketwired | Analysis of Marshall Edwards, Inc.'s OVATURE Trial to Proceed Following Database Lock | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 12/15/2009 | 6:01AM | Edgar (US Regulatory) | Annual and Transition Report (foreign private issuer) (20-F) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 12/01/2009 | 12:01AM | Marketwired | Marshall Edwards, Inc. Appoints Acting CEO | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 11/02/2009 | 6:47AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 11/02/2009 | 6:44AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 09/29/2009 | 8:30AM | Marketwired | Marshall Edwards, Inc.'s NV-128, a Novel mTOR Inhibitor, Demonstrates Good Safety Profile and High Anti-Cancer Activity In Vivo | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 09/29/2009 | 8:21AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 09/22/2009 | 9:03AM | Marketwired | Marshall Edwards, Inc. Receives Nasdaq Notice of Minimum Bid Price Non-Compliance | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 08/27/2009 | 8:05AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 08/07/2009 | 10:04AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 08/05/2009 | 9:12AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 08/05/2009 | 8:05AM | Marketwired | Marshall Edwards Licenses the Investigational Anti-Cancer Compound NV-128 From Novogen Limited | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 07/30/2009 | 8:15AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 07/30/2009 | 8:00AM | Marketwired | Novogen Director Retires | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 07/08/2009 | 11:36AM | PR Newswire (US) | Integrity Media Identifies Market Actives: IFSL, GRVY, NVGN, AMGN, THC, DCP, FDO | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 07/07/2009 | 8:15AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 07/07/2009 | 8:00AM | Marketwired | Researchers Discover That Phenoxodiol Kills Rapidly Proliferating T-Cells | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 06/17/2009 | 9:01AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 06/17/2009 | 8:30AM | Marketwired | Independent Data Monitoring Committee Reviews Marshall Edwards, Inc.'s Arrangements for Data Analysis of the Ovature Trial | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 05/05/2009 | 3:38PM | Edgar (US Regulatory) | Amended Annual and Transition Report (foreign private issuer) (20-F/A) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 04/21/2009 | 6:01AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 04/20/2009 | 8:00AM | Marketwired | Novogen's NV-128 Targets the mTOR Pathway to Block Differentiation and Induce Cell Death in Ovarian Cancer Stem Cells | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 04/14/2009 | 8:32AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 04/14/2009 | 8:20AM | Marketwired | Marshall Edwards, Inc., to Undertake Analysis of Ovature Trial | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 04/08/2009 | 8:04AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |